Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters











Language
Publication year range
1.
Sci Rep ; 14(1): 13915, 2024 06 17.
Article in English | MEDLINE | ID: mdl-38886543

ABSTRACT

The potato cyst nematode Globodera rostochiensis originates from the Andean Mountain region in South America and has unintentionally been introduced to all inhabited continents. Several studies have examined the population genetic structure of this pest in various countries by using microsatellite markers. However, merging microsatellite data produced from different laboratories is challenging and can introduce uncertainty when interpreting the results. To overcome this challenge and to explore invasion routes of this pest, we have genotyped 22 G. rostochiensis populations from all continents. Within populations, the highest genetic diversity was observed in the South American populations, the European populations showed an intermediate level of genetic diversity and the remaining populations were the less diverse. This confirmed pre-existing knowledge such as a first introduction event from South America to Europe, but the less diverse populations could originate either from South America or from Europe. At the continental scale, STRUCTURE genetic clustering output indicated that North America and Asia have experienced at least two introduction events. Comparing different evolutionary scenarios, the Approximate Bayesian Computation analysis showed that Europe served as a secondary distribution centre for the invasion of G. rostochiensis into all other continents (North America, Africa, Asia and Oceania).


Subject(s)
Genetic Variation , Microsatellite Repeats , Solanum tuberosum , Tylenchoidea , Animals , Europe , Solanum tuberosum/parasitology , Tylenchoidea/genetics , Introduced Species , Bayes Theorem , Genotype , Plant Diseases/parasitology , Genetics, Population , South America
2.
JBRA Assist Reprod ; 26(3): 398-406, 2022 08 04.
Article in English | MEDLINE | ID: mdl-34978170

ABSTRACT

OBJECTIVE: Although there has been increased utilization of assisted reproductive technologies (ART) in the world, there is no conclusive definition about the relationship between the success rate of ART and national wealth. METHODS: In this study, using the data from the International Committee for Monitoring Assisted Reproductive Technologies (ICMART), we sought to determine whether there is a correlation between the success rate of ART (represented by pregnancy and delivery rates) and national wealth represented by the gross domestic product (GDP) per capita. Moreover, to further understand the effect of GDP per capita on ART effectiveness, we analyzed the association between ART success rate and GDP per capita in 50 US states. RESULTS: Our data showed that the number of ART treatment cycles increased as the GDP per capita increased. However, we found a negative correlation between ART success rates and GDP per capita in ICMART countries, although no correlation was seen in the US states. Using rough estimation, we derived that the success rate of ART was not related to GDP per capita in the ICMART countries with a GDP per capita greater than USD 13,000. CONCLUSIONS: In conclusion, for the first time, we showed that when the GDP per capita of an economic territory reaches (or exceeds) USD 13,000, ART pregnancy and delivery rates were not associated with GDP per capita, and ART success rates remained stable.


Subject(s)
Gross Domestic Product , Reproductive Techniques, Assisted , Female , Gross Domestic Product/statistics & numerical data , Humans , Pregnancy , Reproductive Techniques, Assisted/statistics & numerical data
3.
PLoS One ; 4(12): e8164, 2009 Dec 03.
Article in English | MEDLINE | ID: mdl-19997603

ABSTRACT

BACKGROUND: We explore vaccination strategies against pandemic influenza in Mexico using an age-structured transmission model calibrated against local epidemiological data from the Spring 2009 A(H1N1) pandemic. METHODS AND FINDINGS: In the context of limited vaccine supplies, we evaluate age-targeted allocation strategies that either prioritize youngest children and persons over 65 years of age, as for seasonal influenza, or adaptively prioritize age groups based on the age patterns of hospitalization and death monitored in real-time during the early stages of the pandemic. Overall the adaptive vaccination strategy outperformed the seasonal influenza vaccination allocation strategy for a wide range of disease and vaccine coverage parameters. CONCLUSIONS: This modeling approach could inform policies for Mexico and other countries with similar demographic features and vaccine resources issues, with regard to the mitigation of the S-OIV pandemic. We also discuss logistical issues associated with the implementation of adaptive vaccination strategies in the context of past and future influenza pandemics.


Subject(s)
Adaptive Immunity/immunology , Disease Outbreaks/prevention & control , Influenza Vaccines/immunology , Influenza, Human/epidemiology , Influenza, Human/prevention & control , Vaccination , Age Distribution , Disease Outbreaks/history , History, 20th Century , Hospitalization , Humans , Incidence , Influenza A Virus, H1N1 Subtype , Influenza, Human/immunology , Influenza, Human/mortality , Mexico/epidemiology , Models, Statistical , Seasons
4.
PLoS Curr ; 1: RRN1004, 2009 Aug 17.
Article in English | MEDLINE | ID: mdl-20025196

ABSTRACT

In this modeling work, we explore the effectiveness of various age-targeted vaccination strategies to mitigate hospitalization and mortality from pandemic influenza, assuming limited vaccine supplies. We propose a novel adaptive vaccination strategy in which vaccination is initiated during the outbreak and priority groups are identified based on real-time epidemiological data monitoring age-specific risk of hospitalization and death. We apply this strategy to detailed epidemiological and demographic data collected during the recent swine A/H1N1 outbreak in Mexico. We show that the adaptive strategy targeting age groups 6-59 years is the most effective in reducing hospitalizations and deaths, as compared with a more traditional strategy used in the control of seasonal influenza and targeting children under 5 and seniors over 65. Results are robust to a number of assumptions and could provide guidance to many nations facing a recrudescence of A/H1N1v pandemic activity in the fall and likely vaccine shortages.

6.
s.l; s.n; 1993. 12 p. tab, graf.
Non-conventional in English | LILACS-Express | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1236761
SELECTION OF CITATIONS
SEARCH DETAIL